Folate-conjugated PEG on single walled carbon nanotubes for targeting delivery of doxorubicin to cancer cells

Research output: Contribution to journalArticlepeer-review

76 Scopus citations

Abstract

A highly effective drug carrier is constructed by coating folic acid-terminated poly(ethylene glycol) (PEG-FA) on single walled carbon nanotubes (SWNTs) in a facile non-covalent method. The anti-cancer drug, doxorubicin (DOX), is further loaded on the surface of SWNTs at a very high loading efficiency, 149.3±4.1%. The drug system (DOX/PEG-FA/SWNTs) exhibits excellent stability under neutral pH conditions such as serum, but dramatically releases DOX at reduced pH typical of the tumour environment and intracellular lysosomes and endosomes. With the help of FA, DOX/PEG-FA/SWNTs tend to selectively attach onto cancer cells and enter the lysosomes or endosomes by clathrin-mediated endocytosis. This can greatly improve the pharmaceutical efficiency and reduce potential side effects.

Original languageEnglish
Pages (from-to)735-744
Number of pages10
JournalMacromolecular Bioscience
Volume13
Issue number6
DOIs
StatePublished - Jun 2013
Externally publishedYes

Keywords

  • Biocompatibility
  • Drug delivery system
  • Folic acid (FA)
  • Poly(ethylene glycol) (PEG)
  • Single walled carbon nanotubes (SWNTs)

Fingerprint

Dive into the research topics of 'Folate-conjugated PEG on single walled carbon nanotubes for targeting delivery of doxorubicin to cancer cells'. Together they form a unique fingerprint.

Cite this